Unique ID issued by UMIN | UMIN000028628 |
---|---|
Receipt number | R000032762 |
Scientific Title | A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan |
Date of disclosure of the study information | 2017/08/10 |
Last modified on | 2020/01/15 11:37:49 |
A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan
A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma
A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan
A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma
Japan |
Melanoma
Dermatology |
Malignancy
NO
Describe treatment patterns in sequential treatment with nivolumab and ipilimumab
Safety,Efficacy
Treatment patterns in sequential treatment with nivolumab and ipilimumab
-Overall response rate (ORR)
-Best overall response rate (BORR)
-Overall survival (OS)
-Progression-free survival (PFS)
-Incidence of treatment-related adverse events (AEs)
-Severity of treatment-related adverse events (AEs)
Observational
18 | years-old | <= |
Not applicable |
Male and Female
-Adult patients > 18 years of age or older
-Diagnosis of advanced melanoma (unresectable/metastatic), alive or deceased as of date of data collection
-Treated with ipilimumab between 31-Aug-2015 and 31-Mar-2017 before or after nivolumab treatment
-Patients enrolled in any clinical trials at any time
-Overlapping use of nivolumab and ipilimumab
82
1st name | |
Middle name | |
Last name | Eijun Itakura |
Bristol-Myers Squibb
Oncology Medical GU & Melanoma
6-5-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-1327
03-6705-7583
eijun.itakura@bms.com
1st name | |
Middle name | |
Last name | Eijun Itakura |
Bristol-Myers Squibb
Oncology Medical GU & Melanoma
6-5-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-1327
03-6705-7583
eijun.itakura@bms.com
Bristol-Myers Squibb
Bristol-Myers Squibb
Profit organization
Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co., Ltd.
YES
CA209-9DA
Bristol-Myers Squibb
NCT03165422
ClinicalTrials.gov
札幌医科大学附属病院(北海道)、国立がん研究センター中央病院(東京都)、信州大学医学部附属病院(長野県)、静岡がんセンター(静岡県)、名古屋大学医学部附属病院(愛知県)、大阪大学医学部附属病院(大阪府)、岡山大学病院(岡山県)、熊本大学医学部附属病院(熊本県)
2017 | Year | 08 | Month | 10 | Day |
Unpublished
Completed
2017 | Year | 03 | Month | 08 | Day |
2017 | Year | 07 | Month | 11 | Day |
2017 | Year | 08 | Month | 24 | Day |
2018 | Year | 03 | Month | 15 | Day |
2018 | Year | 03 | Month | 15 | Day |
2018 | Year | 03 | Month | 31 | Day |
2018 | Year | 05 | Month | 25 | Day |
This is an observational, retrospective medical chart review design that will be implemented with clinical data to be abstracted from patient medical records in Japan.
2017 | Year | 08 | Month | 10 | Day |
2020 | Year | 01 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032762
Research Plan | |
---|---|
Registered date | File name |
2020/01/15 | ca2099da-prot_final.pdf |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |